L

LEGN

Legend Biotech Corporation
HealthcareBiotechnology|NASDAQ Global Select|US

Price

$19.14

Market Cap

$3.54B

Beta

0.06

P/E

0.0

Div Yield

Sector Median P/E

22.6

Key Metrics

Revenue Growth (YoY)+64.22%
EPS Growth (YoY)-67.08%
Revenue CAGR 3Y+111.88%
P/E Ratio0.0
PEG Ratio
FCF Yield-6.52%
Debt / Equity0.41
Interest Coverage-6.3x

Sign up free to unlock full analysis

  • Full 24-factor quality scorecard
  • AI investment committee analysis
  • Factor radar & value trap detection
  • 10-year strategy backtesting
  • Advanced screening & filtering
Get started free

No credit card required

Already have an account? Sign in to view the full analysis for LEGN.

LEGN — Legend Biotech Corporation Stock Analysis | Tessera Alpha